Logo

NHIA touts cancer genome database for precision medicine

NHIA touts cancer genome database for precision medicine

2024-05-14

Since the start of the month, genetic sequencing tests for 19 types of cancer have been included for coverage under national health insurance. In order to conduct precision cancer treatment, the National Health Research Institutes, five pharmaceutical companies and 17 hospitals have joined forces to set up Taiwan’s first genome database, which is expected to benefit more than 20,000 cancer patients every year. Let’s hear from the National Health Insurance Administration.

Shih Chung-liang
NHIA director-general
Next-generation sequencing is separated into three aspects: primarily it’s for corresponding to cancer, and it starts with targeted therapy. The public can also choose to do single gene sequencing, so there’s a variety of options available.

James Chih-Hsin Yang
Superintendent of NTU Cancer Center
The next phase is whether or not it has indication for use. That way we can try using it to see if it has a new method of treatment. This is because for the same gene there can be different diseases and different cancers, and so there’ll be different effects. The effects could be better and they could be worse. We need the platform to collect data in order to know whether these medicines can be used in a broader range of ways.

The NHI says the database can be useful if more targeted drugs are included in the insurance system in the future. It allows medical institutions to check the entries and prevent carrying out multiple tests on the same patient while also providing them with the best treatment for their condition.

For more Taiwan news, tune in:
Sun to Fri at 9:30 pm on Channel 152
Tue to Sat at 1 am on Channel 53

NGS納健保拚"癌症精準醫療" 本土癌症基因庫助2萬癌友

2024-05-14

今年5月開始,健保署將19類癌症的次世代基因定序檢測納入健保給付,為了癌症精準醫療,國衛院與5家國際藥廠以及17家醫院合作,建立台灣第一個本土基因資料庫,預估每年約2萬多名癌症患者受惠。

[[健保署長 石崇良]]
“(次世代基因檢測)分成三個套組,主要是針對有對應藥症的,標靶藥物的基因為點開始納入,構圖不同 另外也有單基因檢測的部份,供民眾選擇,所以這是多元選擇。”

[[台大醫院癌醫中心院長 楊志新]]
“下一個階段就是還沒有通過適應症的,我們可以嘗試使用,看看是不是可以新的治療方式,因為可能相同的基因,在不同的疾病、不同的癌別,會有不同的效果,也許會更好,也許會不好,這些需要平台收集資料以後,才知道這類藥物,是不是可以用在更廣泛的範圍”

健保署強調,未來如果有新的標靶藥物,納入健保給付,醫療機構可透過資料庫查詢,除了避免患者重複檢測,更能對症下藥,成為癌友治療的一大福音。

更多新聞內容,請鎖定:
民視台灣台(152頻道)週日至週五晚上9:30
民視新聞台(53頻道)週二至週六凌晨1:00

Related News

Relatives of Lai Ching-te and Hsiao Bi-khim ready for Inauguration Day

2024-05-14

President Tsai attends Cybersec 2024

2024-05-14

Elementary school archery team from Hualien needs help to get to event in Singapore

2024-05-14

Experts from Taiwan and abroad discuss virtual power plants at ITRI symposium

2024-05-14

Over 17,000 medical visits with enterovirus symptoms mark 10-year high

2024-05-14

Fine cuisine and sports exchanges boost Taiwan-France ties

2024-05-14

Wafer brand offers 100% recyclable packaging

2024-05-14